Skip to main content

Child

0
Pipeline Programs
3
Companies
4
Clinical Trials
2 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
3 programs
High AutonomyN/A1 trial
PICU Up!N/A1 trial
The Home-Based Child Care Toolkit for Nurturing School-Age Children Pilot StudyN/A1 trial
Active Trials
NCT02940431Completed49Est. May 2018
NCT04989790Recruiting1,440Est. Sep 2026
NCT05730075Completed198Est. Oct 2023
Novo Nordisk
Novo NordiskBAGSVAERD DENMARK, Denmark
1 program
VIA Family 2.0N/A
Lundbeck
LundbeckDenmark - Copenhagen
1 program
VIA Family 2.0N/A1 trial
Active Trials
NCT06312410Recruiting1,452Est. Dec 2028

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
LundbeckVIA Family 2.0
Human BioSciencesThe Home-Based Child Care Toolkit for Nurturing School-Age Children Pilot Study
Human BioSciencesPICU Up!
Human BioSciencesHigh Autonomy

Clinical Trials (4)

Total enrollment: 3,139 patients across 4 trials

NCT06312410LundbeckVIA Family 2.0

The VIA Family 2.0 - a Family Based Intervention for Families with Parental Mental Illness

Start: Mar 2024Est. completion: Dec 20281,452 patients
N/ARecruiting
NCT05730075Human BioSciencesThe Home-Based Child Care Toolkit for Nurturing School-Age Children Pilot Study

The Home-Based Child Care Toolkit for Nurturing School-Age Children Pilot Study

Start: Mar 2023Est. completion: Oct 2023198 patients
N/ACompleted
NCT04989790Human BioSciencesPICU Up!

Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children

Start: Aug 2022Est. completion: Sep 20261,440 patients
N/ARecruiting
NCT02940431Human BioSciencesHigh Autonomy

Active Games: Increasing the Attractiveness of Active Video Game Play for Youth

Start: Nov 2016Est. completion: May 201849 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 actively recruiting trials targeting 3,139 patients
3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.